Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
23
# OF OVERLAPPING
HOLDINGS
IBB
247
HOLDINGS
11%
ALSO IN PBE
PBE
28
HOLDINGS
82%
ALSO IN IBB
SECTOR DRIFT (IBB minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 7.4% | 4.9% | 4.9% |
|
AMGEN INC | 7.8% | 4.8% | 4.8% |
|
REGENERON PHARMACEUTICALS | 6.1% | 4.8% | 4.8% |
|
GILEAD SCIENCES INC | 7.4% | 4.6% | 4.6% |
|
BIOGEN IDEC INC | 2.1% | 5.5% | 2.1% |
IBB Overweight Relative to PBE
|
ALNYLAM PHARMACEUTICALS INC | 5.1% |
|
INSMED INC | 3.6% |
 |
ARGENX SE ADR | 3.4% |
|
IQVIA HOLDINGS INC | 3.2% |
|
AMGEN INC | 3.0% |
|
GILEAD SCIENCES INC | 2.8% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
NATERA INC | 2.4% |
|
WATERS CORP | 2.0% |
IBB Underweight Relative to PBE
|
ROYALTY PHARMA PLC CLASS A | -4.7% |
|
BIOGEN IDEC INC | -3.4% |
|
ILLUMINA INC | -3.2% |
|
EXACT SCIENCES CORP | -3.1% |
|
IONIS PHARMACEUTICALS, INC. | -3.1% |
|
SAREPTA THERAPEUTICS INC | -3.0% |
|
INCYTE CORP | -3.0% |
|
PTC THERAPEUTICS INC | -2.9% |
|
VERACYTE INC | -2.9% |
|
CATALYST PHARMACEUTICAL PART | -2.7% |